Clinical Trial Update: ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

View source ↗

Summary

Post-marketing surveillance trial for ALTARGO (retapamulin) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin Infection

Drugs mentioned

• ALTARGO (retapamulin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Infections, Bacterial | Status: COMPLETED